COVID-19 Status Forecasting Using New Viral variants and Vaccination Effectiveness Models

• URL: http://arxiv.org/abs/2201.10356v1
• Date: Mon, 24 Jan 2022 01:28:55 GMT
• Title: COVID-19 Status Forecasting Using New Viral variants and Vaccination Effectiveness Models
• Authors: Essam A. Rashed and Sachiko Kodera and Akimasa Hirata
• Abstract summary: With large variabilities and different co-factors, it is difficult to use conventional mathematical models to forecast the incidence of COVID-19. Data acquired from regions with high rates of vaccination, such as Israel, were blended with the current data of other regions in Japan to factor in the potential effects of vaccination. Using the extracted parameters regarding vaccination effectiveness, new cases in three prefectures of Japan were replicated.
• Score: 2.750124853532831
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Background: Recently, a high number of daily positive COVID-19 cases have been reported in regions with relatively high vaccination rates; hence, booster vaccination has become necessary. In addition, infections caused by the different variants and correlated factors have not been discussed in depth. With large variabilities and different co-factors, it is difficult to use conventional mathematical models to forecast the incidence of COVID-19. Methods: Machine learning based on long short-term memory was applied to forecasting the time series of new daily positive cases (DPC), serious cases, hospitalized cases, and deaths. Data acquired from regions with high rates of vaccination, such as Israel, were blended with the current data of other regions in Japan to factor in the potential effects of vaccination. The protection provided by symptomatic infection was also considered in terms of the population effectiveness of vaccination as well as the waning protection and ratio and infectivity of viral variants. To represent changes in public behavior, public mobility and interactions through social media were also included in the analysis. Findings: Comparing the observed and estimated new DPC in Tel Aviv, Israel, the parameters characterizing vaccination effectiveness and the waning protection from infection were well estimated; the vaccination effectiveness of the second dose after 5 months and the third dose after two weeks from infection by the delta variant were 0.24 and 0.95, respectively. Using the extracted parameters regarding vaccination effectiveness, new cases in three prefectures of Japan were replicated.

Related papers

• Agent-Based Model: Simulating a Virus Expansion Based on the Acceptance of Containment Measures [65.62256987706128]
  Compartmental epidemiological models categorize individuals based on their disease status. We propose an ABM architecture that combines an adapted SEIRD model with a decision-making model for citizens. We illustrate the designed model by examining the progression of SARS-CoV-2 infections in A Coruna, Spain.
  arXiv  Detail & Related papers  (2023-07-28T08:01:05Z)
• Examining Temporalities on Stance Detection towards COVID-19 Vaccination [3.2719621666321412]
  attitudes towards COVID-19 vaccination, such as pro-vaccine or vaccine hesitancy, have evolved over time on social media. This study aims to examine the impact of temporal concept drift on stance detection towards COVID-19 vaccination on Twitter.
  arXiv  Detail & Related papers  (2023-04-10T18:31:26Z)
• Dense Feature Memory Augmented Transformers for COVID-19 Vaccination Search Classification [60.49594822215981]
  This paper presents a classification model for detecting COVID-19 vaccination related search queries. We propose a novel approach of considering dense features as memory tokens that the model can attend to. We show that this new modeling approach enables a significant improvement to the Vaccine Search Insights (VSI) task.
  arXiv  Detail & Related papers  (2022-12-16T13:57:41Z)
• Evaluating vaccine allocation strategies using simulation-assisted causal modelling [7.9656669215132005]
  Early on during a pandemic, vaccine availability is limited, requiring prioritisation of different population groups. We develop a model to retrospectively evaluate age-dependent counterfactual vaccine allocation strategies against the COVID-19 pandemic. We compare Israel's implemented vaccine allocation strategy in 2021 to counterfactual strategies such as no prioritisation, prioritisation of younger age groups or a strict risk-ranked approach.
  arXiv  Detail & Related papers  (2022-12-14T14:24:17Z)
• VacciNet: Towards a Smart Framework for Learning the Distribution Chain Optimization of Vaccines for a Pandemic [0.0]
  We put forward a novel framework leveraging Supervised Learning and Reinforcement Learning (RL) which we call VacciNet. RL is capable of learning to predict the demand of vaccination in a state of a country as well as suggest optimal vaccine allocation in the state for minimum cost of procurement and supply.
  arXiv  Detail & Related papers  (2022-08-01T19:37:33Z)
• A feasibility study proposal of the predictive model to enable the prediction of population susceptibility to COVID-19 by analysis of vaccine utilization for advising deployment of a booster dose [0.0]
  SARS-CoV-2 strain of B1.1.529 or Omicron spreading around the globe. Concerns that it will not end soon and that it will be a race against time until a more contagious and virulent variant emerges. One of the most promising approaches for preventing virus propagation is to maintain continuous high vaccination efficacy.
  arXiv  Detail & Related papers  (2022-04-25T16:05:59Z)
• Modeling the effect of the vaccination campaign on the Covid-19 pandemic [0.0]
  We introduce SAIVR, a mathematical model able to forecast the Covid-19 epidemic evolution during the vaccination campaign. The model contains several parameters and initial conditions that are estimated by employing a semi-supervised machine learning procedure. Instructed by these results, we performed an extensive study on the temporal evolution of the pandemic under varying values of roll-out daily rates, vaccine efficacy, and a broad range of societal vaccine hesitancy/denial levels.
  arXiv  Detail & Related papers  (2021-08-27T19:12:13Z)
• A k-mer Based Approach for SARS-CoV-2 Variant Identification [55.78588835407174]
  We show that preserving the order of the amino acids helps the underlying classifiers to achieve better performance. We also show the importance of the different amino acids which play a key role in identifying variants and how they coincide with those reported by the USA's Centers for Disease Control and Prevention (CDC)
  arXiv  Detail & Related papers  (2021-08-07T15:08:15Z)
• STELAR: Spatio-temporal Tensor Factorization with Latent Epidemiological Regularization [76.57716281104938]
  We develop a tensor method to predict the evolution of epidemic trends for many regions simultaneously. STELAR enables long-term prediction by incorporating latent temporal regularization through a system of discrete-time difference equations. We conduct experiments using both county- and state-level COVID-19 data and show that our model can identify interesting latent patterns of the epidemic.
  arXiv  Detail & Related papers  (2020-12-08T21:21:47Z)
• Predicting seasonal influenza using supermarket retail records [59.18952050885709]
  We consider supermarket retail data as a proxy signal for influenza, through the identification of sentinel baskets. We make use of the Support Vector Regression (SVR) model to produce the predictions of seasonal flu incidence.
  arXiv  Detail & Related papers  (2020-12-08T16:30:43Z)
• Steering a Historical Disease Forecasting Model Under a Pandemic: Case of Flu and COVID-19 [75.99038202534628]
  We propose CALI-Net, a neural transfer learning architecture which allows us to'steer' a historical disease forecasting model to new scenarios where flu and COVID co-exist. Our experiments demonstrate that our approach is successful in adapting a historical forecasting model to the current pandemic.
  arXiv  Detail & Related papers  (2020-09-23T22:35:43Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.